Goldman Sachs
LH icon

Goldman Sachs’s Labcorp LH Stock Holding History

Goldman Sachs’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,820
Closed -$831K – 5452
2020
Q2 		$831K Sell
5,820
-32,592
-85% -$4.51M ﹤0.01% 4078
2020
Q1 		$4.17M Sell
38,412
-19,788
-34% -$2.85M ﹤0.01% 2787
2019
Q4 		$8.46M Hold
58,200
– – ﹤0.01% 2556
2019
Q3 		$8.4M Buy
58,200
+19,555
+51% +$2.85M ﹤0.01% 2457
2019
Q2 		$5.74M Sell
38,645
-78,919
-67% -$11M ﹤0.01% 2750
2019
Q1 		$15.5M Buy
117,564
+102,199
+665% +$12.6M ﹤0.01% 2085
2018
Q4 		$1.67M Sell
15,365
-30,846
-67% -$4.13M ﹤0.01% 3641
2018
Q3 		$6.89M Buy
+46,211
New +$7.03M ﹤0.01% 2746
2017
Q4 		– Sell
-8,148
Closed -$1.06M – 6522
2017
Q3 		$1.06M Buy
8,148
+5,587
+218% +$745K ﹤0.01% 4524
2017
Q2 		$339K Buy
2,561
+1,513
+144% +$185K ﹤0.01% 5398
2017
Q1 		$129K Sell
1,048
-2,328
-69% -$276K ﹤0.01% 5954
2016
Q4 		$372K Sell
3,376
-37,830
-92% -$4.2M ﹤0.01% 5307
2016
Q3 		$4.87M Buy
41,206
+30,497
+285% +$3.59M ﹤0.01% 3069
2016
Q2 		$1.2M Buy
10,709
+8,963
+513% +$965K ﹤0.01% 4047
2016
Q1 		$176K Sell
1,746
-2,561
-59% -$246K ﹤0.01% 5715
2015
Q4 		$457K Sell
4,307
-20,952
-83% -$2.16M ﹤0.01% 5000
2015
Q3 		$2.35M Buy
25,259
+16,063
+175% +$1.66M ﹤0.01% 3627
2015
Q2 		$958K Sell
9,196
-3,755
-29% -$391K ﹤0.01% 4574
2015
Q1 		$1.4M Sell
12,951
-5,906
-31% -$607K ﹤0.01% 4136
2014
Q4 		$1.75M Sell
18,857
-33,989
-64% -$3M ﹤0.01% 3985
2014
Q3 		$4.62M Sell
52,846
-75,660
-59% -$6.84M ﹤0.01% 3102
2014
Q2 		$11.3M Buy
128,506
+105,575
+460% +$9.15M ﹤0.01% 2261
2014
Q1 		$1.94M Buy
22,931
+9,545
+71% +$761K ﹤0.01% 3988
2013
Q4 		$1.05M Buy
13,386
+10,825
+423% +$923K ﹤0.01% 4706
2013
Q3 		$218K Sell
2,561
-2,095
-45% -$176K ﹤0.01% 5810
2013
Q2 		$400K Buy
+4,656
New +$387K ﹤0.01% 5125

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs's LH Position: Q1 2026 in Review

Goldman Sachs reduced its Labcorp (LH) stake by 34% in Q1 2026, selling an estimated $54M and leaving 395,998 shares worth $106M. The position accounts for 0.01% of the portfolio, ranked #990.

Goldman Sachs first reported a position in LH in Q2 2013 and has held it in 51 quarters since. The position peaked at $352M in Q4 2015. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Goldman Sachs held 395,998 shares of Labcorp worth $106M as of Q1 2026.
  • Goldman Sachs sold 199,506 Labcorp shares in Q1 2026, an estimated $54M.
  • Labcorp made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #990 holding.
  • Goldman Sachs first reported a position in Labcorp in Q2 2013 and has held it in 51 quarters since.
  • Goldman Sachs's Labcorp position peaked at $352M in Q4 2015.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.